3 min read
Cleerly: March 14, 2023
Cleerly attended the American College of Cardiology conference (ACC.23/WCC) to showcase our efforts in providing a safe and effective approach to understanding cardiovascular disease risk and guiding personalized treatment. Our team presented...
Read More »3 min read
Cleerly: March 9, 2023
According to the American Heart Association (AHA), nearly half of Americans have some type of cardiovascular disease.1 Despite such wide prevalence, we struggle to provide these patients with the care they need. When patients present to their physicians...
4 min read
Cleerly: February 27, 2023
Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk of major adverse cardiac events (MACE).1 Until recently, though, there had been no clinically useful...
3 min read
Cleerly: February 27, 2023
Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the right services at the right time. This improves outcomes while reducing the utilization of low-quality – and...
4 min read
Cleerly: February 13, 2023
Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals likely had indicators for higher risk, such as high cholesterol or high blood pressure, studies show that up...
4 min read
Cleerly: January 17, 2023
Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to unnecessary and expensive invasive procedures.
Cleerly’s coronary computed tomography angiography...
2 min read
Cleerly: January 17, 2023
Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into provider workflows and patient care journeys.
Our personalized care pathway for heart attack prevention...
3 min read
Cleerly: January 17, 2023
Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease is suspected or identified by these methods, patients must often be referred to a specialist for...
2 min read
Cleerly: January 10, 2023
Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA) imaging that guides physicians towards creating personalized and preventive treatment plans for patients. To...
3 min read
Cleerly: November 9, 2022
Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in Chicago. This event brings together the brightest scientific and clinical minds in cardiovascular and brain...
